Amoxicillin And Clavulanate Potassium Suspension
FDA Label NDC 0143-9853

40 label sections · Submitted to the FDA by Hikma Pharmaceuticals Usa Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Hikma Pharmaceuticals Usa Inc. for the product Amoxicillin And Clavulanate Potassium (NDC 0143-9853). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2.1 important administration instructions, 2.2 dosage in pediatric patients, 2.3 dosage in adult patients, 2.4 dosage in patients with hepatic impairment, 2.5 preparation of the oral suspension, 2.6 switching between dosage forms and between strengths, 3 dosage forms and strengths, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.